Criza medicamentelor bate la ușă

Romania's pharmaceutical sector faces increasing vulnerability, with potential price hikes for medications. Dragoș Damian, CEO of Terapia Cluj, criticizes the government for not prioritizing local drug production as a strategic industry. He advocates for policies that would lower production costs, such as subsidized energy and reduced VAT, similar to practices in Western and Eastern Europe. Currently, Romania produces only 2% of the EU's medication needs, relying heavily on imports. The lack of a strategic approach has hindered foreign investment and local production growth, leaving the country dependent on neighboring nations for pharmaceuticals.